LakeShore Biopharma Co., Ltd: cash_and_restricted_cash
| Value | {"amount": 52201526, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7232761b-01cc-450e-a76c-a83f1059c0d6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-069344Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/cash-and-restricted-cash/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7232761b-01cc-450e-a76c-a83f1059c0d6
History
- supersedes {"amount": 53897845, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001213900-23-060012)